OpenAI Launches GPT-Rosalind Life Sciences Model
GPT-Rosalind Overview
- Developer
- OpenAI
- Model Series
- GPT-Rosalind (first release)
- Focus Areas
- Biology, drug discovery, translational medicine
- Availability
- Research preview for qualified enterprise customers
- Access
- ChatGPT, Codex, API
- Customers
- Amgen, Moderna, Allen Institute, Thermo Fisher Scientific
- Announcement Date
- 2026-04-16
OpenAI introduced GPT-Rosalind, the first in its life sciences model series optimized for biology, drug discovery, and translational medicine research workflows. The model is available as a research preview for qualified enterprise customers including Amgen, Moderna, Allen Institute, and Thermo Fisher Scientific through ChatGPT, Codex, and the API. OpenAI also released a Life Sciences research plugin for Codex connecting to over 50 scientific tools and databases.